METAvivor Research and Support is dedicated to funding research that focuses on improving outcomes for stage IV metastatic breast cancer patients.
Immunotherapy is now part of standard of care for some types of triple negative breast cancer, with much more research ongoing.
Our annual look back at some of the top stories about cancer research and cancer care in the past year.
A look at six essential, but lesser-known, facts about breast cancer.
The Patient-Centered Dosing Initiative is advocating for an approach to cancer medicine dosing that focuses on sustaining lives while also optimizing the quality of life.
My picks for 10 of the top stories about cancer research and cancer care in 2020.
My top three takeaways from the 2020 San Antonio Breast Cancer Symposium.
Top “take-home” highlights from the 2019 San Antonio Breast Cancer Symposium.
The Metastatic Breast Cancer Access to Care Act would waive the lengthy waiting periods that currently prevent individuals with advanced breast cancer from receiving timely access to care.
What stands out in progress against breast cancer over the last five years, and where do we need to do more?